Prenatal Testing

Prenatal testing is one of the most important tools available to protect both mother and baby during pregnancy. These tests help identify potential health concerns early, allowing families and medical teams to prepare, plan, and in many cases, prevent complications that could lead to birth injuries or long-term health challenges.

For families navigating pregnancy, especially those with known risk factors or previous complications, understanding what prenatal testing involves and why it matters can bring both clarity and peace of mind. These tests are not meant to cause worry, but rather to offer knowledge and the opportunity to make informed decisions about care.

What Is Prenatal Testing?

Prenatal testing includes a range of screening and diagnostic procedures performed during pregnancy to assess the health of both the developing baby and the mother. These tests look for chromosomal conditions, genetic disorders, structural abnormalities, infections, and other factors that may affect pregnancy outcomes.

The goal is not only to detect potential problems, but also to guide decisions about where and how delivery should occur, whether specialist care is needed, and what interventions might improve outcomes. When used appropriately, prenatal testing can reduce the risk of preventable birth injuries and ensure that families have access to the right support from the start.

Types of Prenatal Tests

Prenatal tests fall into several categories, each serving a different purpose in monitoring and protecting maternal and fetal health.

Screening Tests

Screening tests estimate the likelihood that a baby may have certain conditions. They do not provide definitive diagnoses, but they help identify pregnancies that may benefit from further testing or closer monitoring.

First-Trimester Screening
This combination of blood tests and ultrasound, performed between 11 and 14 weeks, looks for markers associated with chromosomal abnormalities such as Down syndrome (trisomy 21) and Edwards syndrome (trisomy 18). The ultrasound measures the thickness of fluid at the back of the baby’s neck, called nuchal translucency, which can indicate increased risk when elevated.

Cell-Free DNA Screening
Also known as noninvasive prenatal testing (NIPT), this blood test analyzes small fragments of fetal DNA circulating in the mother’s bloodstream. It screens for common chromosomal conditions with high accuracy and is now offered as an option to all pregnant patients, regardless of age or risk level, according to guidelines from the American College of Obstetricians and Gynecologists (ACOG) and the Society for Maternal-Fetal Medicine (SMFM).

Second-Trimester Screening (Quad Screen)
Performed between 15 and 20 weeks, this blood test measures four substances in maternal blood that can indicate risk for Down syndrome, Edwards syndrome, and neural tube defects such as spina bifida. It includes alpha-fetoprotein (AFP), which is a key marker for open neural tube defects.

Carrier Screening
Carrier screening checks whether one or both parents carry genes for inheritable disorders such as cystic fibrosis, sickle cell disease, Tay-Sachs disease, and fragile X syndrome. Recommendations are based on ethnicity, family history, or universal screening protocols, and help families understand their risk of passing certain conditions to their children.

Diagnostic Tests

When a screening test suggests increased risk, or when there are other clinical concerns, diagnostic tests may be recommended. These provide more definitive answers but carry a small risk of complications, including miscarriage.

Chorionic Villus Sampling (CVS)
Performed between 10 and 13 weeks, CVS involves taking a small sample of placental tissue for genetic testing. It can diagnose chromosomal abnormalities and some genetic disorders earlier in pregnancy than amniocentesis.

Amniocentesis
Typically done between 15 and 20 weeks, amniocentesis involves withdrawing a small amount of amniotic fluid with a thin needle guided by ultrasound. The fluid contains fetal cells that can be analyzed for chromosomal conditions, neural tube defects, and certain genetic disorders. It is considered highly accurate and is one of the most commonly used diagnostic tests.

Both CVS and amniocentesis are performed by experienced specialists, and families receive thorough counseling before and after the procedure to help them understand the results and next steps.

Routine Maternal and Fetal Monitoring

In addition to targeted genetic testing, standard prenatal care includes ongoing monitoring to assess how both mother and baby are doing throughout pregnancy.

Ultrasounds
Routine ultrasounds help track fetal growth, confirm gestational age, assess organ development, and detect structural abnormalities. Anatomy scans, typically performed around 20 weeks, provide detailed views of the baby’s brain, heart, spine, kidneys, and other organs.

Maternal Blood Tests
Pregnant patients are routinely screened for conditions that can affect pregnancy outcomes, including:

• HIV
• Syphilis
• Hepatitis B
• Hepatitis C (now recommended universally by the CDC as of 2023)
• Anemia
• Blood type and Rh factor
• Gestational diabetes (glucose screening between 24 and 28 weeks)

Fetal Monitoring in High-Risk Pregnancies
For pregnancies with complications such as high blood pressure, poor fetal growth, or reduced amniotic fluid, additional monitoring may include:

• Nonstress tests, which measure the baby’s heart rate and response to movement
• Biophysical profiles, which combine ultrasound and heart rate monitoring to assess fetal well-being

These tools help clinicians decide whether early delivery or other interventions are needed to protect the baby.

Newborn Screening

Although performed after birth, newborn screening is a critical extension of prenatal care. In New York and across the United States, every baby is tested within the first day or two of life for more than 50 metabolic, genetic, and hormonal disorders. A few drops of blood are collected from the baby’s heel and sent to a state laboratory.

Early detection of conditions such as phenylketonuria (PKU), congenital hypothyroidism, and sickle cell disease allows for prompt treatment that can prevent intellectual disability, serious illness, and developmental delays. Parents have the right to decline testing for religious reasons, but this requires signing a formal exemption under New York State law.

How Prenatal Testing Helps Prevent Birth Injuries

Prenatal testing plays a direct role in reducing the risk of birth injuries and poor outcomes by identifying conditions that may require specialized care or early intervention.

When tests reveal concerns such as fetal growth restriction, heart defects, neural tube defects, or placental problems, medical teams can:

• Plan for delivery at a hospital with a neonatal intensive care unit (NICU) or other specialized resources
• Coordinate care with maternal-fetal medicine specialists, neonatologists, geneticists, and pediatric surgeons
• Consider earlier delivery if continuing the pregnancy poses greater risk
• Provide treatments during pregnancy, such as medications to support fetal lung development or manage maternal infections

In some cases, knowing about a condition in advance allows for immediate postnatal intervention that can be lifesaving or prevent long-term disability. For example, babies with certain heart defects may need surgery within hours of birth, and advance planning ensures the right team is in place.

At nybirthinjury.com, we provide trusted information to help families understand how timely testing and appropriate medical responses can make a meaningful difference in outcomes.

Who Should Have Prenatal Testing

Current guidelines from the Centers for Disease Control and Prevention (CDC), ACOG, the World Health Organization (WHO), and the New York State Department of Health recommend that all pregnant patients be offered both screening and diagnostic testing options, regardless of age or known risk factors.

In the past, advanced maternal age was the primary reason for offering diagnostic testing. Today, the approach is more inclusive and individualized. Factors that may lead to additional or earlier testing include:

• Family history of genetic conditions or birth defects
• Abnormal results on routine screening tests
• Previous pregnancy affected by a chromosomal abnormality or structural defect
• Ethnic background associated with higher carrier rates for certain disorders
• Maternal health conditions such as diabetes or autoimmune disease
• Findings on ultrasound that suggest a problem

Importantly, prenatal testing is always voluntary. Families have the right to accept or decline any test, and decisions should be made with full understanding of what the test can and cannot reveal, what the risks are, and what follow-up options exist.

Understanding Test Results

One of the most stressful parts of prenatal testing is waiting for results and understanding what they mean. It helps to know a few key points:

Screening tests do not diagnose.
A positive or abnormal screening result means there is an increased risk, not a certainty. Many babies flagged by screening tests are ultimately healthy. Follow-up with diagnostic testing or additional imaging is typically recommended.

Diagnostic tests are highly accurate but not perfect.
While tests like amniocentesis provide definitive answers about chromosomal conditions, no test can detect every possible problem. Some structural or developmental issues may not be apparent until later in pregnancy or after birth.

False positives and false negatives can occur.
Screening tests, in particular, can sometimes indicate a problem that does not exist (false positive) or miss a condition that is present (false negative). This is why counseling and follow-up are so important.

Genetic counselors and maternal-fetal medicine specialists can help interpret results, explain what they mean for the pregnancy, and guide families through next steps. These conversations should always be supportive, clear, and centered on what the family wants and needs to know.

Standards and Guidelines in New York

New York has some of the most comprehensive prenatal and newborn screening programs in the country. State law and health department guidance emphasize early, universal access to testing and follow-up care.

Key standards include:

• Universal offering of genetic screening to all pregnant patients
• Mandatory newborn screening for more than 50 conditions unless parents sign a religious exemption
• Universal screening for hepatitis C during pregnancy, in line with updated 2023 CDC recommendations
• Established networks of regional perinatal centers, such as those at Bellevue Hospital and Columbia Presbyterian, equipped to manage high-risk pregnancies and deliveries

These systems are designed to ensure that no matter where a family lives or receives care, they have access to accurate testing, clear communication, and expert follow-up when needed.

Outcomes and the Importance of Early Detection

The widespread use of prenatal and newborn screening has contributed to significant improvements in infant health over the past few decades. Conditions that once led to severe disability or death are now detected early and managed effectively.

For example:

• Neural tube defects such as spina bifida can be identified during pregnancy, allowing for planning and sometimes fetal surgery
• Congenital heart defects can be diagnosed before birth, enabling delivery at a center with pediatric cardiac surgery capabilities
• Metabolic disorders detected through newborn screening can be treated with diet or medication, preventing intellectual disability and other complications

Despite these successes, disparities remain. Not all families have equal access to high-quality prenatal care, and gaps in education, language support, and follow-up can lead to missed opportunities for intervention. Addressing these disparities is an ongoing priority in maternal and child health.

What Families Can Expect

Prenatal testing should always come with clear communication and support. Families can and should expect:

• Thorough explanations of what each test involves, why it is being offered, and what the results might mean
• Pre-test and post-test counseling that respects their values, concerns, and autonomy
• Referrals to specialists when results indicate a need for further evaluation or care
• Access to genetic counselors, social workers, and other support services
• Coordination with regional perinatal centers if high-risk conditions are identified

No one should feel pressured into testing, and no family should be left alone to navigate confusing or worrying results. Prenatal care is a partnership, and good communication is essential.

Finding Support and Trusted Information

Understanding prenatal testing can feel overwhelming, especially when results raise concerns or difficult decisions need to be made. Families are not alone in this process.

Medical teams, genetic counselors, and support organizations are available to provide guidance, answer questions, and help families make informed choices that align with their values and hopes for their child. When testing reveals a diagnosis or increased risk, early connection with specialists and support networks can make a significant difference in both emotional well-being and medical outcomes.

Prenatal testing is a powerful tool, but it is only one part of a broader commitment to safe, informed, and compassionate pregnancy care.